HSP90AA1 and neurodegenerative disease: Unlike directly inhibiting Hsp90, specifically targeting these Hsp90/co-chaperones PPIs can modulate Hsp90 function by “fine-tuning” and provide an alternative therapeutic strategy for neurodegenerative diseases.